<DOC>
	<DOCNO>NCT00002019</DOCNO>
	<brief_summary>To evaluate safety , tolerance efficacy three different dosage regimens Amphotericin B Lipid Complex ( ABLC ) compare Fungizone ( Amphotericin B ) patient AIDS cryptococcal meningitis .</brief_summary>
	<brief_title>Safety Efficacy Amphotericin B Lipid Complex Treatment Cryptococcal Meningitis Patients With Acquired Immunodeficiency Syndrome</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Meningitis , Cryptococcal</mesh_term>
	<mesh_term>Amphotericin B</mesh_term>
	<mesh_term>Liposomal amphotericin B</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Intravenous pentamidine treatment Pneumocystis carinii pneumonia ( PCP ) prophylaxis . Patients must follow : Meet CDC criterion diagnosis AIDS . Confirmed episode acute cryptococcal meningitis . Informed consent patient guardian prior entry . Exclusion Criteria Coexisting Condition : Patients follow condition symptom exclude : Clinical evidence acute chronic meningitis due agent Cryptococcus neoformans . History hypersensitivity/anaphylactoid reaction attribute amphotericin B . Any concomitant condition , opinion investigator , would preclude patient 's participation study . Concurrent Medication : Excluded : Corticosteroids . Salicylates drug know interfere prostaglandin synthesis except specify protocol . Zidovudine . Investigational agent . Interferon . Interleukin2 ( IL2 ) . Steroids . Isoprinosine . Intrathecal Amphotericin B . Intravenous Pentamidine PCP prophylaxis ( treatment ) . Patients follow exclude : Clinical evidence acute chronic meningitis due agent Cryptococcus neoformans . History hypersensitivity/anaphylactoid reaction attribute amphotericin B . Inability obtain appropriate followup visit . Any concomitant condition , opinion investigator , would preclude patient 's participation study . Prior Medication : Excluded within 4 week study entry : Amphotericin B . Excluded within 2 week study entry : Any experimental drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 1999</verification_date>
	<keyword>Meningitis</keyword>
	<keyword>Liposomes</keyword>
	<keyword>Cryptococcosis</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Amphotericin B</keyword>
	<keyword>Chemistry , Pharmaceutical</keyword>
</DOC>